Ischaemic Stroke News and Research

RSS

CAC-based statin initiation shows no difference in major cardiovascular events

There was no difference in major cardiovascular events when statin initiation was based on coronary artery calcium compared with traditional risk factor assessment, according to results presented in a Hot Line session today at ESC Congress 2026.

31 Aug 2026

Milvexian fails to reduce cardiovascular events after acute coronary syndrome

Milvexian did not reduce major adverse cardiovascular events compared with placebo after a recent acute coronary syndrome and there was no increase in intracranial or fatal bleeding.

29 Aug 2026

New findings do not support the use of edoxaban in AF patients after intracranial hemorrhage

Edoxaban did not reduce stroke or systemic embolism but increased major bleeding in high-risk patients with atrial fibrillation who had had an intracranial hemorrhage, according to results presented in a Hot Line session today at ESC Congress 2026.

29 Aug 2026

Oral anticoagulants benefit patients with atrial fibrillation at intermediate stroke risk

Oral anticoagulant therapy lowered the risk of adverse clinical events compared with no anticoagulation in patients with atrial fibrillation at intermediate stroke risk, according to results from the SINGLE-AF trial presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.

28 Aug 2026

Würzburg researchers discover alternative approach to preventing thrombosis

Glycoprotein VI, or GPVI for short, is a surface receptor found exclusively on platelets and their precursor cells, megakaryocytes in the bone marrow.

14 Aug 2026

Intensive blood pressure control lowers stroke recurrence risk in ICH survivors

Intensive, long-term blood pressure-lowering treatment reduced the risk of recurrent stroke by 38%, without increasing serious adverse events, in people who have survived an intracerebral hemorrhage (ICH).

12 Aug 2026

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events

Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today.

5 Aug 2026

Smart medical wristband tracks hidden arrhythmias to prevent strokes

According to the World Health Organization, cardiovascular diseases claim almost 20 million lives every year and remain the leading cause of death worldwide.

7 Jul 2026

Targeting specific immune pathways could prevent severe reperfusion injury

IRI is a shared pathological process in myocardial infarction, ischaemic stroke, acute kidney injury, lung injury, and graft dysfunction after transplantation.

26 Jun 2026

Evaluating stroke-prevention strategies in patients with atrial fibrillation by age

The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide.

20 May 2026

New research maps the biological toll of drinking

A new review published in the journal Addiction confirms drinking causes substantial harm to health. Some of those harms may be reversible if the person reduces or stops drinking.

14 May 2026

Study challenges long-held assumptions about causes of lacunar stroke

Scientists have uncovered new evidence that challenges long-held assumptions about the causes of a common type of stroke, offering clues as to why widely used treatments may not work.

6 May 2026

Both low and high heart rates linked to stroke risk

A new study presented today at the European Stroke Organisation Conference (ESOC) 2026 suggests that both very low and very high resting heart rates are linked with an increased risk of stroke.

5 May 2026

Climate change increases stroke risk through extreme weather and pollution

The World Stroke Organization is warning that climate change poses an escalating threat to brain health, with extreme heat in particular increasing the risk of having a stroke and of patients dying from stroke.

30 Apr 2026

Heatwaves and coldwaves linked to increase in major cardiovascular events

Heatwaves and coldwaves are associated with increases in major cardiovascular events that are exacerbated by air pollution.

24 Apr 2026

Triple combination pill reduces recurrent stroke risk

Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of another stroke in patients with intracerebral hemorrhage and high blood pressure.

22 Apr 2026

Low birthweight increases stroke risk independent of adult BMI

In new research to be presented at this year's European Congress on Obesity (ECO2026) in Istanbul, Turkey (12-15 May), researchers show an increased risk of stroke in young adulthood for children of low birthweight, independent of their body mass index (BMI) as young adults or gestational age at birth.

3 Apr 2026

Collaboration advances EMA601 as potential first-in-class stroke therapy

Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody EMA601.

30 Mar 2026

AI-assisted decision support system improves stroke care and long-term outcomes

A clinical decision support tool that uses artificial intelligence (AI) to analyze scans after a stroke alongside treatment recommendations is associated with better quality care and long term outcomes for patients compared with usual care, finds a study from China published by The BMJ today.

23 Mar 2026

Gaps in stroke transfer system reduces survivors' chances of receiving critical treatment

Gaps in the U.S. stroke transfer system are drastically reducing survivors' chances of receiving critical treatment and increasing the likelihood that they will leave the hospital with a disability, according to a new study published in The Lancet Neurology.

21 Jan 2026